2019
DOI: 10.36488/cmac.2019.2.134-146
|View full text |Cite
|
Sign up to set email alerts
|

Antimicrobial resistance of pathogens causing community-acquired urinary tract infections in Russia: results of the multicenter study “DARMIS-2018”

Abstract: Цель. Определить in vitro активность антимикробных препаратов в отношении клинических изолятов, выделенных от пациентов с внебольничными инфекциями мочевых путей (ИМП) в различных регионах России в 2017-2018 гг. Материалы и методы. В анализ включено 1052 изолятов порядка Enterobacterales, выделенных в рамках многоцентрового, проспективного, эпидемиологического исследования динамики антибиотикорезистентности возбудителей внебольничных ИМП в различных субпопуляциях пациентов («ДАРМИС-2018») в Российской Федераци… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0
11

Year Published

2019
2019
2024
2024

Publication Types

Select...
10

Relationship

2
8

Authors

Journals

citations
Cited by 31 publications
(14 citation statements)
references
References 7 publications
0
3
0
11
Order By: Relevance
“…Unsurprisingly, however, the main limitation identified by this approach was the lack of consistency and comprehensiveness and high fragmentation of data coming from various research studies. On the other hand, prospective multicenter surveillance studies on resistance of community and nosocomial bacterial pathogens were conducted by the Institute of Antimicrobial Chemotherapy (IAC) and the Interregional Association for Clinical Microbiology and Antimicrobial Chemotherapy (IACMAC) in Russia since the 1990s until the present, which allowed for building a unique collection of clinical isolates and for accumulating large amount of AMR data from centralized testing (Kozlov et al, 2002;Stratchounski et al, 2005;Stratchounski and Rafalski, 2006;Edelstein et al, 2013;Palagin et al, 2019;Sukhorukova et al, 2019). Here, we report the development of the newergeneration web platform, AMRmap (see text footnote 1), for in-depth analysis and visualization of AMR data collected from prospective microbiological surveillance program in Russia whose functionality extends beyond the limits of the existing online resources.…”
Section: Introductionmentioning
confidence: 99%
“…Unsurprisingly, however, the main limitation identified by this approach was the lack of consistency and comprehensiveness and high fragmentation of data coming from various research studies. On the other hand, prospective multicenter surveillance studies on resistance of community and nosocomial bacterial pathogens were conducted by the Institute of Antimicrobial Chemotherapy (IAC) and the Interregional Association for Clinical Microbiology and Antimicrobial Chemotherapy (IACMAC) in Russia since the 1990s until the present, which allowed for building a unique collection of clinical isolates and for accumulating large amount of AMR data from centralized testing (Kozlov et al, 2002;Stratchounski et al, 2005;Stratchounski and Rafalski, 2006;Edelstein et al, 2013;Palagin et al, 2019;Sukhorukova et al, 2019). Here, we report the development of the newergeneration web platform, AMRmap (see text footnote 1), for in-depth analysis and visualization of AMR data collected from prospective microbiological surveillance program in Russia whose functionality extends beyond the limits of the existing online resources.…”
Section: Introductionmentioning
confidence: 99%
“…Результаты приведенных европейских и амери канских исследований соотносятся с данными по следнего крупного многоцентрового исследования «ДАРМИС2018» (Рисунок 2), в котором чувствитель ность изолятов E. coli, выделенных у взрослых с вне больничными ИМП в России (n = 523), составила 97,7% при частоте продукции БЛРС, по данным фенотипичес ких методов, равной 27,0% [12].…”
Section: резистентность уропатогенов к фосфомицина трометамолу и другим ампunclassified
“…P. mirabilis often insulates wounds, forming biofilms, which protects the pathogen from the effects of antimicrobial agents and makes treatment difficult (Leblebicioglu andEsen 2003, Schaffer et al 2016). P. mirabilis is known as an etiological agent of the onset of nosocomial pneumonia (Pаlаgin et al 2012). There is an increased interest towards the role of Proteus in the etiology of rheumatoid arthritis (RA) and towards the development of chemotherapeutic drugs which are active against protei that can reduce the risk of and/or worsening RA development (Ushakova et al 2001, Disaanayake et al 2014.…”
Section: Introductionmentioning
confidence: 99%